LITHANE (lithium carbonate) by R-Pharm US is 12. First approved in 1985.
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
LITHANE is an oral immediate- and sustained-release tablet formulation of lithium carbonate, a small-molecule mood stabilizer approved in 1985. The precise mechanism of action remains unknown, but it is indicated for bipolar disorder management. Lithium is completely absorbed in the upper GI tract, distributed across total body water, and excreted unchanged primarily through the kidneys with an 18–36 hour half-life.
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating a mature asset with likely declining team investment and focus shifting to generics defense or label expansion.
12.1 Mechanism of Action The mechanism of action of lithium as a mood stabilizing agent is unknown. 12.3 Pharmacokinetics Absorption After oral administration, lithium is reported to be completely absorbed in the upper gastrointestinal tract. Peak serum concentrations (T max ) occur 0.25 to 3 hours…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects
Worked on LITHANE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on LITHANE offers limited growth trajectory but provides valuable experience in legacy product lifecycle management, patent defense, and generic transition strategy. Roles are concentrated in commercial sustainment, compliance, and safety rather than innovation-driven expansion.